Medical device company Biovo Technologies Ltd revealed on Thursday that it has commissioned its Cuffix devices in the largest newly established COVID-19 ward in one of Israel's leading hospitals, with a capacity of 170 ventilated patients.
The company added that Cuffix is the first and only economical, self-contained, disposable cuff pressure regulator and monitor in the market.
As ICUs are full and medical personnel is stretched to the limit, the single use products including Cuffix can assist with treating COVID-19 patients and reduce nurse work load. This has dramatically increased worldwide interest in Biovo's products.
Under the company's plan to increase sales and production volumes, it has signed distribution agreements in Australia and Brazil and following the recent 510K FDA clearance, the next commercialization step is in the USA and discussions are already underway.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system